iSpecimen Inc. Diluted Shares Outstanding (Weighted Average)
iSpecimen Inc. (ISPC) reported Diluted Shares Outstanding (Weighted Average) of 1.39 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- iSpecimen Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 1.39M shares, a 2133.89% increase year-over-year.
- iSpecimen Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 341.38K shares, a 487.79% increase year-over-year.
- iSpecimen Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 7.71M shares, a 581.64% increase year-over-year.
- iSpecimen Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 5.84M shares, a 749.83% increase year-over-year.
- iSpecimen Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 4.60M shares, a 547.46% increase from fiscal 2024.
- iSpecimen Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 710.85K shares, a 57.24% increase from fiscal 2023.
- iSpecimen Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 452.07K shares, a 94.89% decline from fiscal 2022.
- iSpecimen Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 8.84M shares, a 106.28% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.39M shares 10-Q · filed 2026-08-14 | 870.86K shares 10-Q · filed 2026-08-14 | 3.15M shares derived: average of 3 quarters · filed 2026-08-14 | 3.82M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 341.38K shares 10-Q · filed 2026-05-18 | 4.03M shares derived: average of 2 quarters · filed 2026-05-18 | 4.63M shares derived: average of 3 quarters · filed 2026-05-18 | 3.49M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 7.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | 6.78M shares derived: average of 2 quarters · filed 2026-04-01 | 4.54M shares derived: average of 3 quarters · filed 2026-08-14 | 4.60M shares 10-K · filed 2026-04-01 | ||||
| 2025-09-30 | 5.84M shares 10-Q · filed 2025-11-17 | 2.95M shares derived: average of 2 quarters · filed 2026-08-14 | 3.57M shares 10-Q · filed 2025-11-17 | 1.77M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 62.42K shares 10-Q · filed 2026-08-14 | 2.50M shares 10-Q · filed 2025-08-14 | 60.26K shares 10-Q · filed 2026-08-14 | 2.41M shares 10-Q · filed 2025-08-14 | 417.28K shares derived: average of 3 quarters · filed 2026-08-14 | 484.74K shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | 58.08K shares 10-Q · filed 2026-05-18 | 2.32M shares 10-Q · filed 2025-05-19 | 594.70K shares derived: average of 2 quarters · filed 2026-05-18 | 625.52K shares derived: average of 3 quarters · filed 2026-05-18 | 610.90K shares derived: average of 4 quarters · filed 2026-05-18 | |||
| 2024-12-31 | 1.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | 909.24K shares derived: average of 2 quarters · filed 2026-04-01 | 795.17K shares derived: average of 3 quarters · filed 2026-04-01 | 710.85K shares 10-K · filed 2026-04-01 | ||||
| 2024-09-30 | 687.15K shares 10-Q · filed 2025-11-17 | 687.14K shares 10-Q · filed 2024-11-07 | 627.09K shares derived: average of 2 quarters · filed 2025-11-17 | 570.69K shares 10-Q · filed 2025-11-17 | 541.15K shares derived: average of 4 quarters · filed 2025-11-17 | |||
| 2024-06-30 | 567.03K shares 10-Q · filed 2025-08-14 | 511.83K shares 10-Q · filed 2025-08-14 | 10.24M shares 10-Q · filed 2024-08-06 | 492.49K shares derived: average of 3 quarters · filed 2025-08-14 | 482.68K shares derived: average of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | 456.62K shares 10-Q · filed 2025-05-19 | 9.13M shares 10-Q · filed 2024-05-07 | 455.21K shares derived: average of 2 quarters · filed 2025-05-19 | 454.57K shares derived: average of 3 quarters · filed 2025-05-19 | 2.60M shares derived: average of 4 quarters · filed 2025-05-19 | |||
| 2023-12-31 | 453.81K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | 453.54K shares derived: average of 2 quarters · filed 2025-04-14 | 3.31M shares derived: average of 3 quarters · filed 2025-04-14 | 452.07K shares 10-K · filed 2025-04-14 | 9.04M shares 10-K · filed 2024-03-13 | |||
| 2023-09-30 | 453.27K shares 10-Q · filed 2024-11-07 | 9.07M shares 10-Q · filed 2023-11-02 | 4.74M shares derived: average of 2 quarters · filed 2024-11-07 | 451.49K shares 10-Q · filed 2024-11-07 | 9.03M shares 10-Q · filed 2023-11-02 | 6.84M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 9.03M shares 10-Q · filed 2023-08-02 | 9.01M shares 10-Q · filed 2024-08-06 | 8.97M shares derived: average of 3 quarters · filed 2024-05-07 | 8.95M shares derived: average of 4 quarters · filed 2024-05-07 | ||||
| 2023-03-31 | 8.98M shares 10-Q · filed 2024-05-07 | 8.95M shares derived: average of 2 quarters · filed 2024-05-07 | 8.92M shares derived: average of 3 quarters · filed 2024-05-07 | 8.90M shares derived: average of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | 8.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 8.89M shares derived: average of 2 quarters · filed 2024-03-13 | 8.87M shares derived: average of 3 quarters · filed 2024-03-13 | 8.84M shares 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | 8.88M shares 10-Q · filed 2023-11-02 | 8.85M shares derived: average of 2 quarters · filed 2023-11-02 | 8.82M shares 10-Q · filed 2023-11-02 | 8.51M shares derived: average of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | 8.82M shares 10-Q · filed 2023-08-02 | 8.79M shares 10-Q · filed 2023-08-02 | 8.39M shares derived: average of 3 quarters · filed 2023-08-02 | 8.03M shares derived: average of 4 quarters · filed 2023-08-02 | ||||
| 2022-03-31 | 8.77M shares 10-Q · filed 2022-05-10 | 8.17M shares derived: average of 2 quarters · filed 2023-03-30 | 7.77M shares derived: average of 3 quarters · filed 2023-03-30 | 6.23M shares derived: average of 4 quarters · filed 2023-03-30 | ||||
| 2021-12-31 | 7.58M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | 7.27M shares derived: average of 2 quarters · filed 2023-03-30 | 5.38M shares derived: average of 3 quarters · filed 2023-03-30 | 4.29M shares 10-K/A · filed 2023-03-30 | ||||
| 2021-09-30 | 6.96M shares 10-Q · filed 2022-11-08 | 4.29M shares derived: average of 2 quarters · filed 2022-11-08 | 3.19M shares 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | 1.61M shares 10-Q · filed 2022-08-04 | 1.27M shares 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | 936.21K shares 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | 936.21K shares 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |